
Recursion Pharmaceuticals Investor Relations Material
Latest events

Q4 2024
Recursion Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Recursion Pharmaceuticals Inc
Access all reports
Segment Data
Access more data
Revenue by
Source
Operating revenue
Grant revenue
Expenses by
Financials
Recursion Pharmaceuticals, Inc. focuses on the development of therapeutics for the treatment of human disease by decoding biology. Their goal is to utilize automation technologies to industrialize drug discovery and replace ineffective trial-and-error drug screening with a streamlined process for identifying new therapeutics.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
RXRX
Country
🇺🇸 United States